Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy for pycnodysostosis
ChiCTR-TNC-10000876Phase 4Completed
- Sponsor
- School of Stomatology, Fourth Military Medical University
- Start
- Jul 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of total glucosides of paeony and thymopeptide in pycnodysostosis (PKND), sponsored by School of Stomatology, Fourth Military Medical University. Primary endpoints: Serum interleukin-17A level, T-cell subset ratio and 2 more. Started Jul 2009; status: completed.
02
Drugs
total glucosides of paeonythymopeptide
03
Conditions
pycnodysostosis (PKND)
Beyond the preview
Go deeper on ChiCTR-TNC-10000876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000876.